Cantor Fitzgerald analyst Olivia Brayer maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price ...

The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was ...

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the ...

Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that its ...

Fourth quarter 2024 GAAP net income attributable to Intuitive was $686 million, or $1.88 per diluted share, compared with $606 million, or $1.69 per diluted share, in the fourth quarter of 2023.

Kassa and others said Big Pharma continues to invest even as private equity funds have pulled back. He noted ...

Goodwin Procter, which arrived in the city early in 2023 with a focus on life sciences deals and private equity, could be an ...

LSL PHARMA GROUP INC. (TSXV: LSL) (TSXV: LSL.DB) ("the Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, announced that it has granted an aggregate of 625,000 share options ...

"Discover how Bruker’s Fourier PAT enables high-fidelity process control and optimization for industrial applications.

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...